| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Incobotulinum Toxin Type A |
| Brand | Xeomin® |
| Indication | For the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults. |
| Assessment Process | |
| Rapid review commissioned | 07/02/2014 |
| Rapid review completed | 05/03/2014 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |